Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial. Everett Meyer, Amandeep Salhotra, Arpita Gandhi, Jeremy Pantin, Sagar S Patel, Rasmus T Hoeg, Alexandra Gomez-Arteaga, Rawan G Faramand, Roni Tamari, Edmund K Waller, Satyajit Kosuri, Antonio M Jimenez Jimenez, Jennifer Holter-Chakrabarty, Bhagirathbhai Dholaria, Yi-Bin Chen, Betty K Hamilton, John M Magenau, Alireza Eghtedar, Joshua M Murray, Anna Pavlova, Nathaniel B Fernhoff, James Scott McClellan, Scott Killian, Ai Li, Robert S Negrin, Caspian Oliai

https://read.qxmd.com/read/41385341/orca-t-versus-allogeneic-hematopoietic-stem-cell-transplantation-precision-t-a-multicenter-randomized-phase-3-trial?uac=148436CN&ecd=wnl_readmost_251226&sso=true&redirected=slug Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial. To prevent graft-versus-host disease (GVHD) in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation (alloHSCT), a calcineurin in.. Dec 12, 2025: Blood